Bírgítte Andersen

Person

Malov, DK

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for inhibiting nuclear receptor subfamily...
- Patent number 11,578,329
- Issue date Feb 14, 2023
- Novo Nordisk A/S
- Utsav Saxena
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
FGF21 derivatives and uses thereof
- Patent number 10,124,039
- Issue date Nov 13, 2018
- Novo Nordisk A/S
- Birgit Wieczorek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
FGF21 derivatives and uses thereof
- Patent number 9,895,417
- Issue date Feb 20, 2018
- Novo Nordisk A/S
- Birgit Wieczorek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FGF21 derivatives and uses thereof
- Patent number 9,744,213
- Issue date Aug 29, 2017
- Novo Nordisk A/S
- Birgit Wieczorek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FGF21 derivatives with albumin binder A-B-C-D-E- and their use
- Patent number 9,480,753
- Issue date Nov 1, 2016
- Novo Nordisk A/S
- Tina Møller Tagmose
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
FUSION COMPOUNDS AND USES THEREOF
- Publication number 20240400635
- Publication date Dec 5, 2024
- Novo Nordisk A/S
- Birgitte Andersen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR INHIBITING NUCLEAR RECEPTOR SUBFAMILY...
- Publication number 20230220398
- Publication date Jul 13, 2023
- Novo Nordisk A/S
- Utsav Saxena
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR INHIBITING NUCLEAR RECEPTOR SUBFAMILY...
- Publication number 20220340912
- Publication date Oct 27, 2022
- Novo Nordisk A/S
- Utsav Saxena
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FGF21 Derivatives and Uses Thereof
- Publication number 20180140673
- Publication date May 24, 2018
- Novo Nordisk A/S
- Birgit Wieczorek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGF21 Derivatives and Uses Thereof
- Publication number 20170354713
- Publication date Dec 14, 2017
- Novo Nordisk A/S
- Birgit Wieczorek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGF21 Derivatives and Uses Thereof
- Publication number 20170182124
- Publication date Jun 29, 2017
- Novo Nordisk A/S
- Birgit Wieczorek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGF21 ANALOGUES AND DERIVATIVES
- Publication number 20130252884
- Publication date Sep 26, 2013
- Novo Nordisk A/S
- Patrick William Garibay
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-TERMINAL MODIFIED FGF21 COMPOUNDS
- Publication number 20130190232
- Publication date Jul 25, 2013
- Novo Nordisk A/S
- Tina Moeller Tagmose
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLP-1 AND FGF21 COMBINATIONS FOR TREATMENT OF DIABETES TYPE 2
- Publication number 20120172298
- Publication date Jul 5, 2012
- Novo Nordisk A/S
- Birgitte Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGF21 ANALOGUES AND DERIVATIVES
- Publication number 20120035099
- Publication date Feb 9, 2012
- Novo Nordisk A/S
- WILLIAM PATRICK GARIBAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGF21 Derivatives With Albumin Binder A-B-C-D-E- And Their Use
- Publication number 20100216715
- Publication date Aug 26, 2010
- Novo Nordisk A/S
- Tina Møller Tagmose
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Bírgítte Andersen

Person

Patents Grantslast 30 patents

Compositions and methods for inhibiting nuclear receptor subfamily...

FGF21 derivatives and uses thereof

FGF21 derivatives and uses thereof

FGF21 derivatives and uses thereof

FGF21 derivatives with albumin binder A-B-C-D-E- and their use

Patents Applicationslast 30 patents

FUSION COMPOUNDS AND USES THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING NUCLEAR RECEPTOR SUBFAMILY...

COMPOSITIONS AND METHODS FOR INHIBITING NUCLEAR RECEPTOR SUBFAMILY...

FGF21 Derivatives and Uses Thereof

FGF21 Derivatives and Uses Thereof

FGF21 Derivatives and Uses Thereof

FGF21 ANALOGUES AND DERIVATIVES

N-TERMINAL MODIFIED FGF21 COMPOUNDS

GLP-1 AND FGF21 COMBINATIONS FOR TREATMENT OF DIABETES TYPE 2

FGF21 ANALOGUES AND DERIVATIVES

FGF21 Derivatives With Albumin Binder A-B-C-D-E- And Their Use